Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

Michael Chuong; Noah Kalman; Federico Albrecht; Paul Kaywin; Guilherme Rabinowits; Carolina Rojas; Minesh Mehta; Rupesh Kotecha

Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

Michael Chuong, Noah Kalman, Federico Albrecht, Paul Kaywin, Guilherme Rabinowits, Carolina Rojas, Minesh Mehta, Rupesh Kotecha

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Jun 19 2022

Cite this

@conference{b5a96a211d24465fb720b26c3ad8afdd,

title = "Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial",

author = "Michael Chuong and Noah Kalman and Federico Albrecht and Paul Kaywin and Guilherme Rabinowits and Carolina Rojas and Minesh Mehta and Rupesh Kotecha",

year = "2022",

month = jun,

day = "19",

language = "American English",

}

TY - CONF

T1 - Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

AU - Chuong, Michael

AU - Kalman, Noah

AU - Albrecht, Federico

AU - Kaywin, Paul

AU - Rabinowits, Guilherme

AU - Rojas, Carolina

AU - Mehta, Minesh

AU - Kotecha, Rupesh

PY - 2022/6/19

Y1 - 2022/6/19

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4667

M3 - Presentation

ER -

Immune checkpoint inhibitor and MR-guided radiation “booster shot” in situ tumor vaccination in patients with limited metastatic carcinoma: interim analysis of a single-arm phase 2 trial

Other files and links

Cite this